The Problem Addressed
by LabPatch


Accurate and frequent monitoring of blood biomarkers is critical for many diseases.  One important example is diabetes, where glucose needs to be continuously tracked to ensure appropriate insulin levels – thereby preventing adverse clinical events like a dangerous hypoglycemic attack.  Diabetics for whom monitoring is indicated might perform fingerstick blood testing several times a day.  Or they will wear a continuous glucose monitor (CGM) by inserting a needle inserted into their abdomen.  While continuous monitoring is recommended by virtually all endocrinologists for a large number of people with diabetes, the invasive and inconvenient aspect of those products has resulted in limited adoption.

testing

testing


Many other diseases can also be managed much more effectively if relevant biomarkers are tracked on a continuous or periodic basis, at clinically indicated intervals. For example:  It is often difficult to determine if chest pain is related to a heart attack; the etiology might be musculoskeletal or gastrointestinal.  Diagnosis is supported by identifying the presence of troponin, which is released into the bloodstream if and when heart muscle is damaged.  The higher the level of troponin, the more damage to the heart.  But at-risk patients need to travel to their doctor or an ER to get evaluated, and the test typically must be repeated several times over 24 hours.  This can be inconvenient and expensive.  Even more significantly, results might not be available for interpretation in a clinically timely manner.


testing

These are just two clinical conditions, albeit prevalent ones, which suffer from the suboptimal clinical-management solutions available today.  There are obviously many other diseases that would receive much more effective/timely diagnosis and treatment if patient-palatable biomarker monitoring were available.